ARCHIVES

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research

June 4, 1993

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

MRI Predicts If Chemo Working In Preoperative Therapy

February 25, 2005